Alergocantabria
- Address
- C. Emilio Pino, 6, 39002 Santander, Spain
Alergocantabria - Allergen Immunotherapy Research Center
Alergocantabria is a specialized medical research center focused on advancing allergen-specific immunotherapy and innovative treatments for respiratory allergic diseases. The center demonstrates particular expertise in developing and evaluating subcutaneous immunotherapy protocols for environmental allergens affecting patients with various severities of allergic conditions.
- Dust mite allergy immunotherapy using polymerized allergen extracts
- Moderate to severe allergic rhinitis and rhinoconjunctivitis treatment
- Controlled mild to moderate allergic asthma management
The center's research program emphasizes evidence-based evaluation of subcutaneous vaccine therapy for patients with intermittent or persistent allergic respiratory conditions. Their clinical trials follow established international classification systems including ARIA guidelines for rhinitis and GEMA protocols for asthma management, ensuring rigorous assessment of both efficacy and safety outcomes in allergen immunotherapy interventions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alergocantabria
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Subcutaneous Dermatophagoides Allergoid Immunotherapy in Allergic Rhinitis/Rhinoconjunctivitis with or without Asthma | Inmunotek S.L. | Phase III | Not Recruiting | Aug 2020 | Apr 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified | 1 | Unknown | 2020-08-05 | 2020-08-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.